203 related articles for article (PubMed ID: 28211519)
1. Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors.
Marotta M; Onodera T; Johnson J; Budd GT; Watanabe T; Cui X; Giuliano AE; Niida A; Tanaka H
Sci Rep; 2017 Feb; 7():41921. PubMed ID: 28211519
[TBL] [Abstract][Full Text] [Related]
2. A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications.
Marotta M; Chen X; Inoshita A; Stephens R; Budd GT; Crowe JP; Lyons J; Kondratova A; Tubbs R; Tanaka H
Breast Cancer Res; 2012 Nov; 14(6):R150. PubMed ID: 23181561
[TBL] [Abstract][Full Text] [Related]
3. The fragility of a structurally diverse duplication block triggers recurrent genomic amplification.
Suzuki R; Murata MM; Manguso N; Watanabe T; Mouakkad-Montoya L; Igari F; Rahman MM; Qu Y; Cui X; Giuliano AE; Takeda S; Tanaka H
Nucleic Acids Res; 2021 Jan; 49(1):244-256. PubMed ID: 33290559
[TBL] [Abstract][Full Text] [Related]
4. Gene copy mapping of the ERBB2/TOP2A region in breast cancer.
Jacobson KK; Morrison LE; Henderson BT; Blondin BA; Wilber KA; Legator MS; O'Hare A; Van Stedum SC; Proffitt JH; Seelig SA; Coon JS
Genes Chromosomes Cancer; 2004 May; 40(1):19-31. PubMed ID: 15034864
[TBL] [Abstract][Full Text] [Related]
5. Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in the intestinal type of gastric cancer.
Vidgren V; Varis A; Kokkola A; Monni O; Puolakkainen P; Nordling S; Forozan F; Kallioniemi A; Vakkari ML; Kivilaakso E; Knuutila S
Genes Chromosomes Cancer; 1999 Jan; 24(1):24-9. PubMed ID: 9892105
[TBL] [Abstract][Full Text] [Related]
6. Assessment of palindromes as platforms for DNA amplification in breast cancer.
Guenthoer J; Diede SJ; Tanaka H; Chai X; Hsu L; Tapscott SJ; Porter PL
Genome Res; 2012 Feb; 22(2):232-45. PubMed ID: 21752925
[TBL] [Abstract][Full Text] [Related]
7. [DNA structural features on the borders of ERBB2 amplicons in breast cancer].
Matsenko NIu; Kovalenko SP
Mol Biol (Mosk); 2013; 47(5):818-27. PubMed ID: 25509354
[TBL] [Abstract][Full Text] [Related]
8. Genome profiling of ERBB2-amplified breast cancers.
Sircoulomb F; Bekhouche I; Finetti P; Adélaïde J; Ben Hamida A; Bonansea J; Raynaud S; Innocenti C; Charafe-Jauffret E; Tarpin C; Ben Ayed F; Viens P; Jacquemier J; Bertucci F; Birnbaum D; Chaffanet M
BMC Cancer; 2010 Oct; 10():539. PubMed ID: 20932292
[TBL] [Abstract][Full Text] [Related]
9. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.
Kallioniemi OP; Kallioniemi A; Kurisu W; Thor A; Chen LC; Smith HS; Waldman FM; Pinkel D; Gray JW
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5321-5. PubMed ID: 1351679
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome and genome evolution during HER2-amplified breast neoplasia.
Lu P; Foley J; Zhu C; McNamara K; Sirinukunwattana K; Vennam S; Varma S; Fehri H; Srivastava A; Zhu S; Rittscher J; Mallick P; Curtis C; West R
Breast Cancer Res; 2021 Jul; 23(1):73. PubMed ID: 34266469
[TBL] [Abstract][Full Text] [Related]
11. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
[TBL] [Abstract][Full Text] [Related]
12. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
Järvinen TA; Tanner M; Bärlund M; Borg A; Isola J
Genes Chromosomes Cancer; 1999 Oct; 26(2):142-50. PubMed ID: 10469452
[TBL] [Abstract][Full Text] [Related]
13. Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes.
Maoz M; Devir M; Inbar M; Inbar-Daniel Z; Sherill-Rofe D; Bloch I; Meir K; Edelman D; Azzam S; Nechushtan H; Maimon O; Uziely B; Kadouri L; Sonnenblick A; Eden A; Peretz T; Zick A
Sci Rep; 2019 Dec; 9(1):18795. PubMed ID: 31827209
[TBL] [Abstract][Full Text] [Related]
14. Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies.
Shiu KK; Wetterskog D; Mackay A; Natrajan R; Lambros M; Sims D; Bajrami I; Brough R; Frankum J; Sharpe R; Marchio C; Horlings H; Reyal F; van der Vijver M; Turner N; Reis-Filho JS; Lord CJ; Ashworth A
Oncogene; 2014 Jan; 33(5):619-31. PubMed ID: 23334330
[TBL] [Abstract][Full Text] [Related]
15. Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer.
Kauraniemi P; Kallioniemi A
Endocr Relat Cancer; 2006 Mar; 13(1):39-49. PubMed ID: 16601278
[TBL] [Abstract][Full Text] [Related]
16. Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2
Vasmatzis G; Wang X; Smadbeck JB; Murphy SJ; Geiersbach KB; Johnson SH; Gaitatzes AG; Asmann YW; Kosari F; Borad MJ; Serie DJ; McLaughlin SA; Kachergus JM; Necela BM; Thompson EA
BMC Cancer; 2018 Jul; 18(1):738. PubMed ID: 30005627
[TBL] [Abstract][Full Text] [Related]
17. Amplification and overexpression of the ABCC3 (MRP3) gene in primary breast cancer.
Partanen L; Staaf J; Tanner M; Tuominen VJ; Borg Å; Isola J
Genes Chromosomes Cancer; 2012 Sep; 51(9):832-40. PubMed ID: 22585709
[TBL] [Abstract][Full Text] [Related]
18. Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.
Bièche I; Tomasetto C; Régnier CH; Moog-Lutz C; Rio MC; Lidereau R
Cancer Res; 1996 Sep; 56(17):3886-90. PubMed ID: 8752152
[TBL] [Abstract][Full Text] [Related]
19. Amplification of HSD17B1 and ERBB2 in primary breast cancer.
Gunnarsson C; Ahnström M; Kirschner K; Olsson B; Nordenskjöld B; Rutqvist LE; Skoog L; Stål O
Oncogene; 2003 Jan; 22(1):34-40. PubMed ID: 12527905
[TBL] [Abstract][Full Text] [Related]
20. Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis.
Christgen M; van Luttikhuizen JL; Raap M; Braubach P; Schmidt L; Jonigk D; Feuerhake F; Lehmann U; Schlegelberger B; Kreipe HH; Steinemann D
Oncotarget; 2016 Dec; 7(50):82733-82740. PubMed ID: 27716627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
